semaglutide / tirzepetide Tirzepatide vs. Semaglutide: A Complete Comparison Guide The GLP-1 Powerhouses: Semaglutide vs.

For a spicy kick, sprinkle red chili flakes over the popped corn

The investigational triple agonist retatrutide is in Phase 3 trials with dosage regimens still being optimized

Cardiologists cover the SELECT trial results, blood pressure, cholesterol, and cardiovascular outcomes

Always use peptide therapy under a healthcare professional's supervision

The affected medications include: Semaglutide (Ozempic, Rybelsus, Wegovy) Liraglutide (Saxenda, Victoza) Tirzepatide (Mounjaro, Zepbound) New Warning Details The updated label now includes a subsection under "Warnings and Precautions" that states: "There have been rare postmarketing reports of pulmonary aspiration in patients receiving GLP-1 receptor agonists undergoing elective surgeries or procedures requiring general anesthesia or deep sedation who had residual gastric contents despite reported adherence to preoperative fasting recommendations." This warning highlights the potential risk of stomach contents entering the lungs during surgical procedures, even when patients have followed fasting guidelines